Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes

Ramez M. Ali, Lina T. Al Kury, Keun Hang Susan Yang, Anwar Qureshi, Mohanraj Rajesh, Sehamuddin Galadari, Yaroslav M. Shuba, Frank Christopher Howarth, Murat Oz

Research output: Contribution to journalArticle

Abstract

Cannabidiol (CBD), a major nonpsychotropic cannabinoid found in Cannabis plant, has been shown to influence cardiovascular functions under various physiological and pathological conditions. In the present study, the effects of CBD on contractility and electrophysiological properties of rat ventricular myocytes were investigated. Video edge detection was used to measure myocyte shortening. Intracellular Ca2+ was measured in cells loaded with the Ca2+ sensitive fluorescent indicator fura-2 AM. Whole-cell patch clamp was used to measure action potential and Ca2+ currents. Radioligand binding was employed to study pharmacological characteristics of CBD binding. CBD (1μM) caused a significant decrease in the amplitudes of electrically evoked myocyte shortening and Ca2+ transients. However, the amplitudes of caffeine-evoked Ca2+ transients and the rate of recovery of electrically evoked Ca2+ transients following caffeine application were not altered. CBD (1μM) significantly decreased the duration of APs. Further studies on L-type Ca2+ channels indicated that CBD inhibits these channels with IC50 of 0.1μM in a voltage-independent manner. Radioligand studies indicated that the specific binding of [3H]Isradipine, was not altered significantly by CBD. The results suggest that CBD depresses myocyte contractility by suppressing L-type Ca2+ channels at a site different than dihydropyridine binding site and inhibits excitation-contraction coupling in cardiomyocytes.

Original languageEnglish (US)
Pages (from-to)290-299
Number of pages10
JournalCell Calcium
Volume57
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Cannabidiol
Calcium Signaling
Muscle Cells
Caffeine
Isradipine
Excitation Contraction Coupling
Cannabinoids
Fura-2
Cannabis
Cardiac Myocytes
Action Potentials
Inhibitory Concentration 50
Binding Sites
Pharmacology

Keywords

  • Calcium channels
  • Cannabidiol
  • Cannabinoid
  • Contraction
  • Intracellular calcium
  • Ventricular myocytes

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Cite this

Ali, R. M., Al Kury, L. T., Yang, K. H. S., Qureshi, A., Rajesh, M., Galadari, S., ... Oz, M. (2015). Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. Cell Calcium, 57(4), 290-299. https://doi.org/10.1016/j.ceca.2015.02.001

Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. / Ali, Ramez M.; Al Kury, Lina T.; Yang, Keun Hang Susan; Qureshi, Anwar; Rajesh, Mohanraj; Galadari, Sehamuddin; Shuba, Yaroslav M.; Howarth, Frank Christopher; Oz, Murat.

In: Cell Calcium, Vol. 57, No. 4, 01.04.2015, p. 290-299.

Research output: Contribution to journalArticle

Ali, RM, Al Kury, LT, Yang, KHS, Qureshi, A, Rajesh, M, Galadari, S, Shuba, YM, Howarth, FC & Oz, M 2015, 'Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes', Cell Calcium, vol. 57, no. 4, pp. 290-299. https://doi.org/10.1016/j.ceca.2015.02.001
Ali, Ramez M. ; Al Kury, Lina T. ; Yang, Keun Hang Susan ; Qureshi, Anwar ; Rajesh, Mohanraj ; Galadari, Sehamuddin ; Shuba, Yaroslav M. ; Howarth, Frank Christopher ; Oz, Murat. / Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. In: Cell Calcium. 2015 ; Vol. 57, No. 4. pp. 290-299.
@article{70af30a69d414c8392bae5cbac415957,
title = "Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes",
abstract = "Cannabidiol (CBD), a major nonpsychotropic cannabinoid found in Cannabis plant, has been shown to influence cardiovascular functions under various physiological and pathological conditions. In the present study, the effects of CBD on contractility and electrophysiological properties of rat ventricular myocytes were investigated. Video edge detection was used to measure myocyte shortening. Intracellular Ca2+ was measured in cells loaded with the Ca2+ sensitive fluorescent indicator fura-2 AM. Whole-cell patch clamp was used to measure action potential and Ca2+ currents. Radioligand binding was employed to study pharmacological characteristics of CBD binding. CBD (1μM) caused a significant decrease in the amplitudes of electrically evoked myocyte shortening and Ca2+ transients. However, the amplitudes of caffeine-evoked Ca2+ transients and the rate of recovery of electrically evoked Ca2+ transients following caffeine application were not altered. CBD (1μM) significantly decreased the duration of APs. Further studies on L-type Ca2+ channels indicated that CBD inhibits these channels with IC50 of 0.1μM in a voltage-independent manner. Radioligand studies indicated that the specific binding of [3H]Isradipine, was not altered significantly by CBD. The results suggest that CBD depresses myocyte contractility by suppressing L-type Ca2+ channels at a site different than dihydropyridine binding site and inhibits excitation-contraction coupling in cardiomyocytes.",
keywords = "Calcium channels, Cannabidiol, Cannabinoid, Contraction, Intracellular calcium, Ventricular myocytes",
author = "Ali, {Ramez M.} and {Al Kury}, {Lina T.} and Yang, {Keun Hang Susan} and Anwar Qureshi and Mohanraj Rajesh and Sehamuddin Galadari and Shuba, {Yaroslav M.} and Howarth, {Frank Christopher} and Murat Oz",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.ceca.2015.02.001",
language = "English (US)",
volume = "57",
pages = "290--299",
journal = "Cell Calcium",
issn = "0143-4160",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes

AU - Ali, Ramez M.

AU - Al Kury, Lina T.

AU - Yang, Keun Hang Susan

AU - Qureshi, Anwar

AU - Rajesh, Mohanraj

AU - Galadari, Sehamuddin

AU - Shuba, Yaroslav M.

AU - Howarth, Frank Christopher

AU - Oz, Murat

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Cannabidiol (CBD), a major nonpsychotropic cannabinoid found in Cannabis plant, has been shown to influence cardiovascular functions under various physiological and pathological conditions. In the present study, the effects of CBD on contractility and electrophysiological properties of rat ventricular myocytes were investigated. Video edge detection was used to measure myocyte shortening. Intracellular Ca2+ was measured in cells loaded with the Ca2+ sensitive fluorescent indicator fura-2 AM. Whole-cell patch clamp was used to measure action potential and Ca2+ currents. Radioligand binding was employed to study pharmacological characteristics of CBD binding. CBD (1μM) caused a significant decrease in the amplitudes of electrically evoked myocyte shortening and Ca2+ transients. However, the amplitudes of caffeine-evoked Ca2+ transients and the rate of recovery of electrically evoked Ca2+ transients following caffeine application were not altered. CBD (1μM) significantly decreased the duration of APs. Further studies on L-type Ca2+ channels indicated that CBD inhibits these channels with IC50 of 0.1μM in a voltage-independent manner. Radioligand studies indicated that the specific binding of [3H]Isradipine, was not altered significantly by CBD. The results suggest that CBD depresses myocyte contractility by suppressing L-type Ca2+ channels at a site different than dihydropyridine binding site and inhibits excitation-contraction coupling in cardiomyocytes.

AB - Cannabidiol (CBD), a major nonpsychotropic cannabinoid found in Cannabis plant, has been shown to influence cardiovascular functions under various physiological and pathological conditions. In the present study, the effects of CBD on contractility and electrophysiological properties of rat ventricular myocytes were investigated. Video edge detection was used to measure myocyte shortening. Intracellular Ca2+ was measured in cells loaded with the Ca2+ sensitive fluorescent indicator fura-2 AM. Whole-cell patch clamp was used to measure action potential and Ca2+ currents. Radioligand binding was employed to study pharmacological characteristics of CBD binding. CBD (1μM) caused a significant decrease in the amplitudes of electrically evoked myocyte shortening and Ca2+ transients. However, the amplitudes of caffeine-evoked Ca2+ transients and the rate of recovery of electrically evoked Ca2+ transients following caffeine application were not altered. CBD (1μM) significantly decreased the duration of APs. Further studies on L-type Ca2+ channels indicated that CBD inhibits these channels with IC50 of 0.1μM in a voltage-independent manner. Radioligand studies indicated that the specific binding of [3H]Isradipine, was not altered significantly by CBD. The results suggest that CBD depresses myocyte contractility by suppressing L-type Ca2+ channels at a site different than dihydropyridine binding site and inhibits excitation-contraction coupling in cardiomyocytes.

KW - Calcium channels

KW - Cannabidiol

KW - Cannabinoid

KW - Contraction

KW - Intracellular calcium

KW - Ventricular myocytes

UR - http://www.scopus.com/inward/record.url?scp=84930383022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930383022&partnerID=8YFLogxK

U2 - 10.1016/j.ceca.2015.02.001

DO - 10.1016/j.ceca.2015.02.001

M3 - Article

C2 - 25711828

AN - SCOPUS:84930383022

VL - 57

SP - 290

EP - 299

JO - Cell Calcium

JF - Cell Calcium

SN - 0143-4160

IS - 4

ER -